Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
12.75
-0.53 (-3.99%)
Apr 25, 2025, 10:28 AM EDT - Market open
Capricor Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$39.29
Upside
+208.16%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $30 | Buy | Reiterates | $30 | +135.29% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +503.92% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +503.92% | Mar 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +503.92% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +503.92% | Jan 2, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +213.73% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +503.92% | Nov 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $25 → $30 | Buy | Maintains | $25 → $30 | +135.29% | Nov 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $35 | Buy | Initiates | $35 | +174.51% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $77 | Strong Buy | Maintains | $40 → $77 | +503.92% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +213.73% | Oct 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $15 → $43 | Buy | Maintains | $15 → $43 | +237.25% | Sep 25, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $12 → $25 | Strong Buy | Maintains | $12 → $25 | +96.08% | Sep 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +213.73% | Sep 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $15 | Buy | Reiterates | $15 | +17.65% | Sep 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | -37.25% | Sep 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.